1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-07-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 08574962 2024-07-01 2025-06-30 08574962 2025-06-30 08574962 2024-06-30 08574962 2023-07-01 2024-06-30 08574962 2024-06-30 08574962 2023-06-30 08574962 core:MotorVehicles 2024-07-01 2025-06-30 08574962 bus:OrdinaryShareClass1 2024-07-01 2025-06-30 08574962 bus:Director1 2024-07-01 2025-06-30 08574962 core:WithinOneYear 2025-06-30 08574962 core:WithinOneYear 2024-06-30 08574962 core:MotorVehicles 2024-06-30 08574962 core:MotorVehicles 2025-06-30 08574962 core:ShareCapital 2025-06-30 08574962 core:ShareCapital 2024-06-30 08574962 core:RetainedEarningsAccumulatedLosses 2025-06-30 08574962 core:RetainedEarningsAccumulatedLosses 2024-06-30 08574962 core:MotorVehicles 2024-06-30 08574962 bus:SmallEntities 2024-07-01 2025-06-30 08574962 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 08574962 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 08574962 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 08574962 bus:FullAccounts 2024-07-01 2025-06-30 08574962 bus:OrdinaryShareClass1 2025-06-30 08574962 bus:OrdinaryShareClass1 2024-06-30 08574962 core:ComputerEquipment 2024-07-01 2025-06-30 08574962 core:ComputerEquipment 2024-06-30 08574962 core:ComputerEquipment 2025-06-30 08574962 core:OtherRelatedParties 2024-07-01 2025-06-30
COMPANY REGISTRATION NUMBER: 08574962

Marlow Medical Limited

Filleted Unaudited Financial Statements

30 June 2025

Marlow Medical Limited

Financial Statements

Year ended 30 June 2025

Contents | Page

Statement of financial position | 1

Notes to the financial statements | 3

Marlow Medical Limited

Statement of Financial Position

30 June 2025

| 2025 | 2024
Note | £ | £ | £ | £

Fixed assets

Tangible assets | 5 |  | 30,049 |  | 39,996

Current assets

Debtors | 6 | 1,597 |  | 4,509 |
Cash at bank and in hand | 76,305 |  | 111,803 |
| -------- |  | --------- |
| 77,902 |  | 116,312 |

Creditors: amounts falling due within one year | 7 | 62,479 |  | 65,538 |
| -------- |  | --------- |
Net current assets |  | 15,423 |  | 50,774
|  | -------- |  | --------
Total assets less current liabilities |  | 45,472 |  | 90,770

Provisions

Taxation including deferred tax |  | 7,512 |  | 9,999
|  | -------- |  | --------
Net assets |  | 37,960 |  | 80,771
|  | -------- |  | --------

Capital and reserves

Called up share capital | 8 |  | 100 |  | 100
Profit and loss account |  | 37,860 |  | 80,671
|  | -------- |  | --------
Shareholders funds |  | 37,960 |  | 80,771
|  | -------- |  | --------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Marlow Medical Limited

Statement of Financial Position (continued)

30 June 2025
These financial statements were approved by the board of directors and authorised for issue on 24 March 2026 , and are signed on behalf of the board by:

Dr J Siew Sun Lam |
Director |

Company registration number: 08574962

Marlow Medical Limited

Notes to the Financial Statements

Year ended 30 June 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 8 Nancy Edwards Place, Chelmsford, Essex, CM1 2WU.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed assets
All fixed assets are initially recorded at cost.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Motor vehicles | - | 25% reducing balance
| Computer equipment | - | 25% straight line

Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
5. Tangible assets

| Motor vehicles | Equipment | Total
| £ | £ | £
Cost |  |  |
At 1 July 2024 | 54,325 | 8,403 | 62,728
Additions | – | 1,257 | 1,257
| -------- | ------- | --------
At 30 June 2025 | 54,325 | 9,660 | 63,985
| -------- | ------- | --------
Depreciation |  |  |
At 1 July 2024 | 16,118 | 6,614 | 22,732
Charge for the year | 9,551 | 1,653 | 11,204
| -------- | ------- | --------
At 30 June 2025 | 25,669 | 8,267 | 33,936
| -------- | ------- | --------
Carrying amount |  |  |
At 30 June 2025 | 28,656 | 1,393 | 30,049
| -------- | ------- | --------
At 30 June 2024 | 38,207 | 1,789 | 39,996
| -------- | ------- | --------

6. Debtors

| 2025 | 2024
| £ | £
Trade debtors | 1,597 | 4,509
| ------- | -------

7. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Accruals and deferred income | 1,778 | 1,694
Corporation tax | 42,532 | 40,704
Social security and other taxes | 687 | 134
Director loan accounts | 6,889 | 13,790
Other creditors | 10,593 | 9,216
| -------- | --------
| 62,479 | 65,538
| -------- | --------

8. Called up share capital
Issued, called up and fully paid

| 2025 | 2024
| No. | £ | No. | £
Ordinary shares of £ 1 each | 100 | 100 | 100 | 100
| ---- | ---- | ---- | ----

9. Related party transactions
At the year end the company owed the director £6,889 (2023: £13,790) by way of a loan account. This loan, which is shown amongst creditors, is interest free and repayable on demand.